301206 三元生物
已收盘 06-26 15:00:00
资讯
新帖
简况
三元生物（301206）披露股东减持计划时间届满未减持公告，6月26日股价下跌3.03%
证券之星 · 06-26 17:56
三元生物（301206）披露股东减持计划时间届满未减持公告，6月26日股价下跌3.03%
股市必读：三元生物（301206）6月23日董秘有最新回复
证券之星 · 06-24
股市必读：三元生物（301206）6月23日董秘有最新回复
每周股票复盘：三元生物（301206）推232.57万股限制性股票
证券之星 · 06-21
每周股票复盘：三元生物（301206）推232.57万股限制性股票
6月16日三元生物现1笔折价19.02%的大宗交易 合计成交289.95万元
证券之星 · 06-16
6月16日三元生物现1笔折价19.02%的大宗交易 合计成交289.95万元
三元生物：公司2025年归属于上市公司股东的净利润为9141.06万元
证券之星 · 06-11
三元生物：公司2025年归属于上市公司股东的净利润为9141.06万元
三元生物：截至5月29日公司在册股东共14936户
证券之星 · 06-10
三元生物：截至5月29日公司在册股东共14936户
三元生物：技术研发与销售团队在公司激励体系中占据重要位置
证券之星 · 06-09
三元生物：技术研发与销售团队在公司激励体系中占据重要位置
三元生物(301206.SZ)：年产2万吨阿洛酮糖项目正式投产
智通财经 · 06-03
三元生物(301206.SZ)：年产2万吨阿洛酮糖项目正式投产
三元生物（301206）披露继续使用暂时闲置超募资金进行现金管理进展，6月2日股价下跌2.07%
证券之星 · 06-02
三元生物（301206）披露继续使用暂时闲置超募资金进行现金管理进展，6月2日股价下跌2.07%
三元生物(301206.SZ)拟推2026年限制性股票激励计划
智通财经 · 05-25
三元生物(301206.SZ)拟推2026年限制性股票激励计划
三元生物（301206）披露2025年年度股东会决议公告，5月21日股价下跌2.52%
证券之星 · 05-21
三元生物（301206）披露2025年年度股东会决议公告，5月21日股价下跌2.52%
恒瑞医药与BMS刷新合作纪录；默沙东与多家药企签署协议
21世纪经济报道 · 05-13
恒瑞医药与BMS刷新合作纪录；默沙东与多家药企签署协议
5月12日三元生物发布公告，股东减持100万股
证券之星 · 05-12
5月12日三元生物发布公告，股东减持100万股
三元生物：截至5月8日公司在册股东共15862户
证券之星 · 05-11
三元生物：截至5月8日公司在册股东共15862户
三元生物(301206)4月30日股东户数1.56万户，较上期增加1.2%
证券之星 · 05-07
三元生物(301206)4月30日股东户数1.56万户，较上期增加1.2%
股市必读：三元生物（301206）5月6日董秘有最新回复
证券之星 · 05-07
股市必读：三元生物（301206）5月6日董秘有最新回复
三元生物：2025年末存货增长主要系公司基于市场预判进行的战略性备货
证券之星 · 05-06
三元生物：2025年末存货增长主要系公司基于市场预判进行的战略性备货
三元生物（301206）披露2026年一季度报告，4月29日股价上涨3.49%
证券之星 · 04-29
三元生物（301206）披露2026年一季度报告，4月29日股价上涨3.49%
图解三元生物年报：第四季度单季净利润同比增长0.28%
证券之星 · 04-29
图解三元生物年报：第四季度单季净利润同比增长0.28%
股市必读：三元生物（301206）4月22日董秘有最新回复
证券之星 · 04-23
股市必读：三元生物（301206）4月22日董秘有最新回复
加载更多
公司概况
公司名称：
山东三元生物科技股份有限公司
所属行业：
食品制造业
上市日期：
2022-02-10
主营业务：
山东三元生物科技股份有限公司的主营业务是糖醇类、功能糖类及糖苷类健康甜味配料的研发、生产与销售。公司的主要产品是赤藓糖醇、阿洛酮糖、塔格糖、甜菊糖。公司品牌先后荣获“山东知名品牌”及“山东优质品牌”称号。
发行价格：
109.30
{"stockData":{"symbol":"301206","market":"SZ","secType":"STK","nameCN":"三元生物","latestPrice":22.41,"timestamp":1782457389000,"preClose":23.11,"halted":0,"volume":1230550,"delay":0,"changeRate":-0.0303,"floatShares":130000000,"shares":202000000,"eps":0.4577,"marketStatus":"已收盘","change":-0.7,"latestTime":"06-26 15:00:00","open":22.99,"high":23.17,"low":22.36,"amount":27764400,"amplitude":0.035,"askPrice":22.46,"askSize":31,"bidPrice":22.41,"bidSize":27,"shortable":0,"etf":0,"ttmEps":0.4577,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782696600000},"marketStatusCode":5,"adr":0,"adjPreClose":23.11,"symbolType":"stock","openAndCloseTimeList":[[1782437400000,1782444600000],[1782450000000,1782457200000]],"highLimit":25.42,"lowLimit":20.8,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":202325700,"isCdr":false,"pbRate":1.1,"roa":"--","peRate":48.962202,"roe":"0.61%","epsLYR":0.46,"committee":-0.175879,"marketValue":4534000000,"turnoverRate":0.0094,"status":1,"floatMarketCap":2919000000},"requestUrl":"/m/hq/s/301206","defaultTab":"news","newsList":[{"id":"2646235578","title":"三元生物（301206）披露股东减持计划时间届满未减持公告，6月26日股价下跌3.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646235578","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646235578?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:56","pubTimestamp":1782467812,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，三元生物报收于22.41元，较前一交易日下跌3.03%，最新总市值为45.34亿元。公司于近日披露《关于股东减持计划时间届满未减持的公告》。公告显示，山东三元生物科技股份有限公司于2026年3月4日披露了股东鲁信资本拟在2026年3月26日至6月25日期间通过集中竞价方式减持不超过1,930,000股的计划。截至2026年6月25日，减持计划时间届满，鲁信资本未实施减持，仍持有公司股份1,930,000股，占总股本的0.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600033578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645851835","title":"股市必读：三元生物（301206）6月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2645851835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645851835?lang=zh_cn&edition=full","pubTime":"2026-06-24 04:26","pubTimestamp":1782246372,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，三元生物报收于24.04元，上涨0.17%，换手率0.84%，成交量1.09万手，成交额2639.61万元。董秘最新回复投资者： 松谷化学的合作到什么程度了董秘： 投资者您好！公司始终致力于全球市场的拓展，并与众多国际知名企业开展了广泛而深入的业务合作与交流。当日关注点交易信息汇总：6月23日主力资金净流出163.07万元，占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400004554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645962590","title":"每周股票复盘：三元生物（301206）推232.57万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2645962590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645962590?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:25","pubTimestamp":1781983512,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，三元生物报收于23.74元，较上周的24.0元下跌1.08%。本周，三元生物6月15日盘中最高价报24.34元。来自公司公告汇总：三元生物确定2026年6月18日为授予日，向76名激励对象授予232.57万股第二类限制性股票，授予价格为13.42元/股。交易信息汇总6月16日三元生物发生1笔大宗交易，成交价较收盘价折价19.02%，合计成交金额289.95万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643758607","title":"6月16日三元生物现1笔折价19.02%的大宗交易 合计成交289.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643758607","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643758607?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:27","pubTimestamp":1781602052,"startTime":"0","endTime":"0","summary":"证券之星消息，6月16日三元生物发生大宗交易，交易数据如下：大宗交易成交价格19.33元，相对当日收盘价折价19.02%，成交15万股，成交金额289.95万元，买方营业部为中信建投证券股份有限公司济南双山大街证券营业部，卖方营业部为中信建投证券股份有限公司济南龙奥北路证券营业部。近三个月该股共发生2笔大宗交易，合计成交3000.0手，折价成交2笔。截至2026年6月16日收盘，三元生物报收于23.87元，下跌1.12%，换手率0.85%，成交量1.1万手，成交额2628.99万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600030612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642403148","title":"三元生物：公司2025年归属于上市公司股东的净利润为9141.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642403148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642403148?lang=zh_cn&edition=full","pubTime":"2026-06-11 11:36","pubTimestamp":1781148983,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年净利润2491万元，扣除理财收入2534万元与利息收入671万元，实际上是亏损的。原因何在？三元生物回复：投资者您好！公司2025年归属于上市公司股东的净利润为9141.06万元。你提到的“净利润2491万元”实为公司2025年第一季度归属于上市公司股东的净利润额。公司主营业务和整体经营均保持稳健，不存在亏损的情况，详细财务数据敬请查阅公司披露的《2025年年度报告》。感谢您的关注与支持！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100014941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642941407","title":"三元生物：截至5月29日公司在册股东共14936户","url":"https://stock-news.laohu8.com/highlight/detail?id=2642941407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642941407?lang=zh_cn&edition=full","pubTime":"2026-06-10 11:34","pubTimestamp":1781062443,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问5月29日的股东人数是多少？三元生物回复：投资者您好，截至5月29日公司在册股东共14936户，谢谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000017338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642459840","title":"三元生物：技术研发与销售团队在公司激励体系中占据重要位置","url":"https://stock-news.laohu8.com/highlight/detail?id=2642459840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642459840?lang=zh_cn&edition=full","pubTime":"2026-06-09 11:33","pubTimestamp":1780976005,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物06月08日在投资者关系平台上答复投资者关心的问题。建议股权激励一类的奖励多考虑给技术部门或者销售部门一定的倾斜。技术研发与销售团队作为创新和开拓市场的核心，在公司的激励体系中一直都占据着重要位置。除股权激励外，公司也为研发和销售部门量身定制了专项考核激励办法，充分调动和保护大家的积极性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900015054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640972333","title":"三元生物(301206.SZ)：年产2万吨阿洛酮糖项目正式投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2640972333","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640972333?lang=zh_cn&edition=full","pubTime":"2026-06-03 15:55","pubTimestamp":1780473356,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三元生物(301206.SZ)发布公告，近日，公司实施的“年产2万吨阿洛酮糖项目”中剩余1万吨阿洛酮糖产能(简称“该项目”)顺利完成主体工程建设、设备安装调试及前期相关准备和验收工作，并正式投产。随着该项目的正式投产，公司“年产2万吨阿洛酮糖项目”已实现全线投产。后续，公司将结合产品工艺、生产流程及市场需求，稳妥、有序地推进产能释放与市场开拓工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三元生物(301206.SZ)：年产2万吨阿洛酮糖项目正式投产","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640391463","title":"三元生物（301206）披露继续使用暂时闲置超募资金进行现金管理进展，6月2日股价下跌2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640391463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640391463?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:11","pubTimestamp":1780395081,"startTime":"0","endTime":"0","summary":"近日，山东三元生物科技股份有限公司披露《关于继续使用暂时闲置超募资金进行现金管理的进展公告》。公告显示，公司于2026年2月4日召开第五届董事会第十一次会议，审议通过继续使用不超过60,000万元人民币的暂时闲置超募资金进行现金管理，使用期限为12个月内，资金可滚动使用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200036216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638555589","title":"三元生物(301206.SZ)拟推2026年限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2638555589","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638555589?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:09","pubTimestamp":1779718169,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三元生物(301206.SZ)披露2026年限制性股票激励计划(草案)，拟向激励对象授予的限制性股票数量为232.57万股，约占激励计划草案公告时公司股本总额的1.15%。本次授予为一次性授予，无预留权益。拟授予的激励对象共计76人，授予价格为13.42元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637387393","title":"三元生物（301206）披露2025年年度股东会决议公告，5月21日股价下跌2.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637387393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637387393?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:36","pubTimestamp":1779359779,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，三元生物报收于25.94元，较前一交易日下跌2.52%，最新总市值为52.48亿元。该股当日开盘26.62元，最高26.91元，最低25.9元，成交额达3550.63万元，换手率为1.03%。近日，山东三元生物科技股份有限公司发布《2025年年度股东会决议公告》。公告显示，公司于2026年5月20日召开2025年年度股东会，会议由董事会召集，董事长聂在建主持，采用现场与网络投票相结合方式召开。出席会议股东共75人，代表有表决权股份总数的48.3227%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635221419","title":"恒瑞医药与BMS刷新合作纪录；默沙东与多家药企签署协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2635221419","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635221419?lang=zh_cn&edition=full","pubTime":"2026-05-13 08:02","pubTimestamp":1778630577,"startTime":"0","endTime":"0","summary":"政策动向国家药监局局长黄果会见新加坡卫生科学局局长蔡瑞文双方就创新医疗器械等议题深入交换意见国家药监局局长黄果5月11日在京会见了来访的新加坡卫生科学局局长蔡瑞文一行，并签署《中华人民共和国国家药品监督管理局与新加坡共和国卫生科学局监管合作谅解备忘录》。双方就细胞和基因治疗、创新医疗器械及人工智能产品监管等议题深入交换意见。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605133735150673.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605133735150673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0106261372.USD","LU2491050154.USD","LU0211331839.USD","LU0320765489.SGD","688506","LU2361044865.SGD","LU0965509010.AUD","LU1997245094.SGD","BK0028","LU1061106388.HKD","LU0359201885.HKD","LU1064131003.USD","LU2543165471.USD","LU1201861249.SGD","BK0239","BK4533","SG9999002224.SGD","BK4550","LU1929549753.HKD","BK4559","LU2488822045.USD","BK4516","301206","LU1069347547.HKD","LU1974910355.USD","SG9999014575.USD","SG9999002232.USD","LU0942090050.USD","LU2491049909.HKD","LU2360032135.SGD","BK4534","IE0009355771.USD","LU1066053197.SGD","BK0188","LU0648001328.SGD","MRK","LU1116320737.USD","LU1989772840.SGD","LU2580892862.HKD","LU1066051811.HKD","LU0130102774.USD","LU1969619763.USD","LU1917777945.USD","LU1781817850.SGD","IE00BJJMRZ35.SGD","IE00BLSP4452.SGD","SG9999015341.SGD","BK0196","600276","LU0208291251.USD","LU0203347892.USD","LU1057294990.SGD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU1820825898.SGD","LU1146622755.USD","LU0238689110.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU1941712264.USD","LU1585245621.USD","LU0130517989.USD","LU1255011170.USD","LU2357627491.SGD","BK0183","LU0320765646.SGD","LU0405327494.USD","LU1655091616.SGD","LU2097828474.EUR","LU0985320562.USD","IE0002141913.USD","LU0266013472.USD","BK0012","LU0006306889.USD","LU2106854487.HKD","LU1066051225.USD","LU1093756325.SGD","IE00BBT3K403.USD","LU1037948541.HKD","LU2361044949.HKD","SG9999014542.SGD","LU0980610538.SGD","BK4585","LU0861579265.USD","002022","IE000M9KFDE8.USD","LU2468319806.SGD","LU1430594728.SGD","LU1093756168.USD","LU1989772923.USD","IE00BSNM7G36.USD","LU0965509101.SGD","LU1997245177.USD","LU0432979614.USD","BK0060","LU2461242641.AUD","LU1328615791.USD","LU2097828714.EUR","LU2495084118.USD","BK4588","LU0203345920.USD","LU0234572021.USD","LU1580142542.USD","LU0122379950.USD","LU0868494708.USD","LU0098860793.USD","LU1023057109.AUD","BK4007","LU1571399168.USD","SG9999001176.SGD","LU2089984988.USD","LU2148510915.USD","LU1934455194.USD","SG9999015358.SGD","LU0405327148.USD","01276","LU1989771016.USD","LU1997244956.HKD","LU2324357040.USD","LU2023250843.SGD","IE00B2B36J28.USD","LU0859254822.USD","LU1291159041.SGD","SG9999001440.SGD","SG9999014559.SGD","LU1983299246.USD","LU0868494617.USD","LU2097828557.USD","LU0965509283.SGD","SG9999013999.USD","LU2097828631.EUR","LU1162221912.USD","LU1116320901.HKD","LU0070302665.USD","LU0289739699.SGD","LU0477156953.USD","LU1934455863.HKD","IE00BN8TJ469.HKD","LU2361045086.USD","IE00B1BXHZ80.USD","LU1066051498.USD","LU1941712348.USD","LU2112291526.USD","LU1035773651.USD","LU2097828805.USD","LU0265550359.USD","LU2491050071.SGD","BK1191","SG9999014567.USD","LU2125154778.USD","LU1064130708.USD","LU0965508806.USD","LU1037948897.HKD","LU1699723380.USD","LU0359201612.USD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU2328871848.SGD","LU2580892789.USD","IE00B4R5TH58.HKD","LU2125154935.USD","LU2289578879.USD","LU2023250504.SGD","SG9999001176.USD","LU0359202008.SGD","LU0265550946.USD","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634216715","title":"5月12日三元生物发布公告，股东减持100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634216715","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634216715?lang=zh_cn&edition=full","pubTime":"2026-05-12 20:01","pubTimestamp":1778587300,"startTime":"0","endTime":"0","summary":"证券之星消息，5月12日三元生物发布公告《三元生物:关于持股5%以上股东权益变动触及1%整数倍暨减持计划实施完成的公告》，其股东吕熙安于2026年5月6日至2026年5月11日间合计减持100.0万股，占公司目前总股本的0.4943%，变动期间该股股价上涨0.81%，截止5月11日收盘报27.45元。股东增减持详情见下表：根据三元生物2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200036501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634090244","title":"三元生物：截至5月8日公司在册股东共15862户","url":"https://stock-news.laohu8.com/highlight/detail?id=2634090244","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634090244?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:48","pubTimestamp":1778489296,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)05月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问5月8日的股东人数是多少？三元生物回复：投资者您好，截至5月8日公司在册股东共15862户，谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633387114","title":"三元生物(301206)4月30日股东户数1.56万户，较上期增加1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633387114","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633387114?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:38","pubTimestamp":1778146739,"startTime":"0","endTime":"0","summary":"证券之星消息，近日三元生物披露，截至2026年4月30日公司股东户数为1.56万户，较4月10日增加185.0户，增幅为1.2%。在化学制品行业个股中，三元生物股东户数低于行业平均水平，截至4月30日，化学制品行业平均股东户数为2.78万户。从股价来看，2026年4月10日至2026年4月30日，三元生物区间涨幅为2.56%，在此期间股东户数增加185.0户，增幅为1.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700029277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633153436","title":"股市必读：三元生物（301206）5月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2633153436","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633153436?lang=zh_cn&edition=full","pubTime":"2026-05-07 02:02","pubTimestamp":1778090543,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，三元生物报收于27.12元，下跌0.4%，换手率1.23%，成交量1.61万手，成交额4380.59万元。随着2026年一季度营业收入实现同比49.65%的增长，前期储备存货正有序消化，不存在滞销情形。审计机构已出具报告，认定公司于2025年12月31日按照《企业内部控制基本规范》和相关规定，在所有重大方面保持了有效的财务报告内部控制。当日关注点来自交易信息汇总：5月6日主力资金净流出717.87万元，散户资金净流入856.47万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700001375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633790275","title":"三元生物：2025年末存货增长主要系公司基于市场预判进行的战略性备货","url":"https://stock-news.laohu8.com/highlight/detail?id=2633790275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633790275?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:00","pubTimestamp":1778054431,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物05月06日在投资者关系平台上答复投资者关心的问题。投资者提问：年报显示2025年存货余额增至1.75亿元，营收却下滑8.89%，存货跌价准备仅27万元。2025年末存货增长主要系公司基于市场预判进行的战略性备货。随着2026年一季度营业收入实现同比49.65%的增长，前期储备存货正有序消化，不存在滞销情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600021987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631071515","title":"三元生物（301206）披露2026年一季度报告，4月29日股价上涨3.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631071515","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631071515?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:53","pubTimestamp":1777463585,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，三元生物报收于27.01元，较前一交易日上涨3.49%，最新总市值为54.65亿元。该股当日开盘26.33元，最高27.11元，最低26.24元，成交额达6223.33万元，换手率为1.78%。公司于2026年4月29日披露《2026年一季度报告》。报告显示，2026年第一季度营业收入为224,781,048.39元，较上年同期增长49.65%；归属于上市公司股东的净利润为26,091,444.30元，同比增长4.73%；归属于上市公司股东的扣除非经常性损益的净利润为22,862,806.87元，同比增长9.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900060906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631258277","title":"图解三元生物年报：第四季度单季净利润同比增长0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631258277","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631258277?lang=zh_cn&edition=full","pubTime":"2026-04-29 01:39","pubTimestamp":1777397988,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物2025年年报显示，当年度公司主营收入6.5亿元，同比下降8.89%；归母净利润9141.06万元，同比下降12.9%；扣非净利润7593.59万元，同比下降25.9%；其中2025年第四季度，公司单季度主营收入1.73亿元，同比下降12.4%；单季度归母净利润2401.19万元，同比上升0.28%；单季度扣非净利润1880.16万元，同比下降18.28%；负债率4.07%，投资收益6951.18万元，财务费用-507.28万元，毛利率16.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900004576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629070078","title":"股市必读：三元生物（301206）4月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2629070078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629070078?lang=zh_cn&edition=full","pubTime":"2026-04-23 04:39","pubTimestamp":1776890343,"startTime":"0","endTime":"0","summary":"截至2026年4月22日收盘，三元生物报收于26.15元，下跌0.42%，换手率0.6%，成交量7829.0手，成交额2045.69万元。董秘最新回复投资者： 董秘你好，有客户成批量购买贵公司的甜菊糖苷Rm了吗？公司莱鲍迪苷M目前处于市场拓展与导入阶段，已获得部分下游客户的积极反馈，市场推广工作有序开展。出于商业秘密保护要求，具体业务合作细节不便对外披露。交易信息汇总资金流向4月22日主力资金净流出192.95万元；游资资金净流入68.23万元；散户资金净流入124.72万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300010837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782680224996,"stockEarnings":[{"period":"1week","weight":-0.056},{"period":"1month","weight":-0.1121},{"period":"3month","weight":-0.1311},{"period":"6month","weight":-0.1525},{"period":"1year","weight":-0.1875},{"period":"ytd","weight":-0.1476}],"compareEarnings":[{"period":"1week","weight":-0.0155},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.029},{"period":"6month","weight":0.016},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东三元生物科技股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"14964人(较上一季度增加0.19%)","perCapita":"8705股","listingDate":"2022-02-10","address":"山东省滨州市滨城区滨北张富路89号","registeredCapital":"20232万元","survey":" 山东三元生物科技股份有限公司的主营业务是糖醇类、功能糖类及糖苷类健康甜味配料的研发、生产与销售。公司的主要产品是赤藓糖醇、阿洛酮糖、塔格糖、甜菊糖。公司品牌先后荣获“山东知名品牌”及“山东优质品牌”称号。","listedPrice":109.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三元生物,301206,三元生物股票,三元生物股票老虎,三元生物股票老虎国际,三元生物行情,三元生物股票行情,三元生物股价,三元生物股市,三元生物股票价格,三元生物股票交易,三元生物股票购买,三元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}